Orchestra BioMed (NASDAQ:OBIO – Get Free Report) will likely be issuing its quarterly earnings data before the market opens ...

BTIG analyst Marie Thibault initiated coverage of Orchestra BioMed (OBIO) with a Buy rating and $12 price target Orchestra is a medical ...

Fintel reports that on March 20, 2025, BTIG initiated coverage of Orchestra BioMed Holdings (NasdaqGM:OBIO) with a Buy recommendation. Analyst Price Forecast Suggests 247.03% Upside As of March 19, ...

BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This page features the latest news about the Orchestra Biomed Holdings stock. OBIO stock touches 52-week low at $3.75 amid market challenges In a challenging market environment, Health Sciences ...

Pacitti serves as chair of the AdvaMed Medical Imaging Technology Division's board of directors and on the boards for Orchestra BioMed and the Siemens Foundation. The views and opinions expressed ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report), Sandoz ...

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David ...